Efficacy of alogliptin in preventing non-alcoholic fatty liver disease progression in patients with type 2 diabetes

Por MASHITANI, TSUYOSHI, NOGUCHI, RYUICHI, OKURA, YASUSHI, NAMISAKI, TADASHI, MITORO, AKIRA, ISHII, HITOSHI, NAKATANI, TOSHIYA, KIKUCHI, EIRYO, MORIYASU, HIROTO, MATSUMOTO, MASAMI, SATO, SHINYA, AN, TATSUICHI, MORITA, HIROSHI, AIZAWA, SIGEYUKI, TOKUOKA, YASUNORI, ISHIKAWA, MASATOSHI, MATSUMURA, YOSHINOBU, OHIRA, HIROMASA, KOGURE, ATSUKO, NOGUCHI, KAZUHIRO, YOSHIJI, HITOSHI
Publicado no Biomed Rep (2016)